TNFSF10 and Alzheimer disease: Consistently, the TNFSF10 neutralizing antibody improved cognitive function (Cantarella et al. 2015), while reducing pathological protein accumulation, and inflammation in 3xTg-AD mice when administered during an early phase of AD (Di Benedetto et al. 2019).